Access count of this item: 1648

Files in This Item:
File Description SizeFormat 
56_473.pdf1.67 MBAdobe PDFView/Open
Title: 虚血腎機能障害に対するエリスロポエチンの腎保護作用についての検討 (第58回日本泌尿器科学会中部総会(金沢))
Other Titles: Renal Protective Effects of Erythropoietin on Ischemic Reperfusion Injury
Authors: 森山, 学  KAKEN_name
田中, 達朗  KAKEN_name
鈴木, 孝治  KAKEN_name
Author's alias: Moriyama, Manabu
Tanaka, Tatsuro
Suzuki, Koji
Keywords: Erythropoietin
Marginal donor
Ischemia
Reperfusion injury (IRI)
Kidney transplantation
Issue Date: Aug-2010
Publisher: 泌尿器科紀要刊行会
Journal title: 泌尿器科紀要
Volume: 56
Issue: 8
Start page: 473
End page: 479
Abstract: We reexamined the conditions of tissue disorders resulting from temporary ischemia of the organs as well as changes in tissue function and the effects on the preservation of renal function over time by using rat models in order to clinically utilize erythropoietin, which has inhibitory effects on ischemia-reperfusion disorders. In 8- to 9-week-old Wister male rats, after the right kidney had been resected under general anesthesia, the left renal artery was clamped to inhibit the blood flow for 45 minutes. At 30 minutes before inhibiting the blood flow and after releasing the inhibited blood flow, 100 U/kg of recombinant human erythropoietin (rhEPO) was administered via the inferior vena cava and the abdominal cavity, and then the tissues and blood samples were extracted at 6 hours and 24 hours after the release. The renal tissue specimens were evaluated for apoptosis and renal function using hematoxylin eosin staining and TUNEL staining. Changes in the emergence of active oxygen were investigated by using blood samples. The degree of renal dysfunction was evaluated by measuring neutrophil gelatinase-associated lipocalin (NGAL) in the spot urine samples. The changes in the serum creatinine level, showed that the renal function was preserved with a significant difference in the rhEPO administration group. The liver deviation enzymes clearly decreased in the rhEPO administration group. Active oxygen did not change before and after the ischemia-reperfusion nor was it changed by rhEPO administration. Apoptosis was inhibited by rhEPO administration. No direct effects of rhEPO administration on the emergence of active oxygen were observed. The administration of rhEPO, was suggested to help preserve the renal function in marginal donors with a longer agonal stageby effectively.
Rights: 許諾条件により本文は2011-09-01に公開
URI: http://hdl.handle.net/2433/123558
PubMed ID: 20808070
Appears in Collections:Vol.56 No.8

Show full item record

Export to RefWorks


Export Format: 


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.